Top

Published in:

01-03-2015 | Review Article

Mesopancreas in Pancreatic Cancer: Where do We Stand – Review of Literature

Authors: Ramachandra Chowdappa, Vasu Reddy Challa

Published in: Indian Journal of Surgical Oncology | Issue 1/2015

Abstract

Pancreatic cancer is associated with poor prognosis and surgery remains the main modality of treatment. Negative resection margin is an important prognostic factor for survival. Retropancreatic margin or the medial margin is the most common site of positive resection margin. Mesopancreas was proposed in analogy with mesorectum, which is considered as a fusion fascia formed embryologically during the development of pancreas. This mesopancreas lies posterior to the pancreas and contains pancreaticoduodenal vessels, lymphatics, nerve plexus and loose areolar tissue. Various technical modifications were proposed for better dissection of mesopancreas like posterior approach and artery first approach. There is an increased rate of R0 resection by these technical modifications but whether this will turn to increase in survival rates is yet to be established.

Globocan (2008) http://globocan.iarc.fr/factsheet.asp

Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, Schramm H, Fahlke J, Zuelke C, Burkart C, Gutberlet K, Kettner E, Schmalenberg H, Weigang-Koehler K, Bechstein WO, Niedergethmann M, Schmidt-Wolf I, Roll L, Doerken B, Riess H (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267–277CrossRefPubMed

Richter A, Niedergethmann M, Sturm JW, Lorenz D, Post S, Trede M (2003) Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 27:324–329CrossRefPubMed

Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Buchler MW (2004) Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91:586–594CrossRefPubMed

Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, Hruban RH, Ord SE, Sauter PK, Coleman J, Zahurak ML, Grochow LB, Abrams RA (1997) Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 226:248–257CrossRefPubMedCentralPubMed

Hishinuma S, Ogata Y, Tomikawa M, Ozawa I, Hirabayashi K, Igarashi S (2006) Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg 10:511–518CrossRefPubMed

Kayahara M, Nagakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I (1993) An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 72:2118–2123CrossRefPubMed

Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H, Schirmacher P, Buchler MW (2008) Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 15:1651–1660CrossRefPubMed

Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A (2006) Redefining the R1 resection in pancreatic cancer. Br J Surg 93:1232–1237CrossRefPubMed

10.

Michalski CW, Kleeff J, Wente MN, Diener MK, Buchler MW, Friess H (2007) Systematic review and metaanalysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg 94:265–273CrossRefPubMed

11.

Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger H, Pederzoli P (2001) Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 234:758–768CrossRefPubMedCentralPubMed

12.

Heald RJ, Husband EM, Ryall RD (1982) The mesorectum in rectal cancer surgery – the clue to pelvic recurrence? Br J Surg 69:613–616CrossRefPubMed

13.

Gockel I, Domeyer M, Wolloscheck T, Konerding MA, Junginger T (2007) Resection of the mesopancreas (RMP): a new surgical classification of a known anatomical space. World J Surg Oncol 5:44CrossRefPubMedCentralPubMed

14.

Mehrabi A, Mood ZA, Roshanaei N, Fonouni H, Müller SA, Schmied BM, Hinz U, Weitz J, Büchler MW, Schmidt J (2008) Mesohepatectomy as an option for the treatment of central liver tumors. J Am Coll Surg 207(4):499–509CrossRefPubMed

15.

Matsubara T, Ueda M, Nagao N, Takahashi T, Nakajima T, Nishi M (1998) Cervicothoracic approach for total mesoesophageal dissection in cancer of the thoracic esophagus. J Am Coll Surg 187(3):238–245CrossRefPubMed

16.

Gien LT, Covens A (2009) Total mesometrial resection for cancer of the cervix: the future surgical procedure, or oblivion? Lancet Oncol 10(7):644–645CrossRefPubMed

17.

Xie D, Osaiweran H, Liu L, Wang X, Yu C, Tong Y, Hu J, Gong J (2013) Mesogastrium: a fifth route of metastasis in gastric cancer? Med Hypotheses 80(4):498–500CrossRefPubMed

18.

Borghi F, Gattolin A, Garbossa D, Bogliatto F, Garavoglia M, Levi AC (1998) Embryologic bases of extended radical resection in pancreatic cancer. Arch Surg 133(3):297–301CrossRefPubMed

19.

Morton A. Meyers (5th edition). Dynamic Radiology of the Abdomen: Normal and Pathologic Anatomy, Springer (United states of America)

20.

Agrawal MK, Thakur DS, Somashekar U, Chandrakar SK, Sharma D (2010) Mesopancreas: myth or reality? JOP 11(3):230–233PubMed

21.

Moldovan SC, Moldovan AM, Dumitraæcu T, Andrei S, Popescu I (2012) The advantages of retropancreatic vascular dissection for pancreatic head cancer with portal/superior mesenteric vein invasion: posterior approach pancreatico-duodenectomy technique and the mesopancreas theory. Chirurgia (Bucur) 107(5):571–578

22.

Popescu I, Dumitrascu T (2011) Total meso-pancreas excision: key point of resection in pancreatic head adenocarcinoma. Hepatogastroenterology 58(105):202–207PubMed

23.

Howard JM (1999) Development and progress in resective surgery for pancreatic cancer. World J Surg 23(9):901–906CrossRefPubMed

24.

Kausch W (1912) [Das Carcinom der Papilla duodeni und seine radikale Entfernung] in German. Beitr Z Klin Chir 78:439–486

25.

Whipple AO, Parsons WB, Mullins CR (1935) Treatment of carcioma of the ampulla of Vater. Ann Surg 102(4):763–779CrossRefPubMedCentralPubMed

26.

Howard JH (1997) Historical aspects and the future of pancreatoduodenectomy. In: Hanyu F, Takasaki K (eds) Pancreatoduodenectomy. Springer-Verlag, Tokyo, pp 3–10CrossRef

27.

Gudjonsson B (2002) Survival statistics gone awry: pancreatic cancer, a case in point. J Clin Gastroenterol 35:180–184CrossRefPubMed

28.

Hirota M, Kanemitsu K, Takamori H, Chikamoto A, Tanaka H, Sugita H et al (2010) Pancreatoduodenectomy using a no-touch isolation technique. Am J Surg 199(5):e65–e68CrossRefPubMed

29.

Nagakawa T, Sanada H, Inagaki M, Sugama J, Ueno K, Konishi I et al (2004) Long-term survivors after resection of carcinoma of the head of the pancreas: significance of histologically curative resection. J Hepatobiliary Pancreat Surg 11(6):402–408CrossRefPubMed

30.

Pawlik TM, Gleisner AL, Cameron JL, Winter JM, Assumpcao L, Lillemoe KD et al (2007) Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 141(5):610–618CrossRefPubMed

31.

Schmidt CM, Glant J, Winter JM, Kennard J, Dixon J, Zhao Q et al (2007) Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma. Surgery 142(4):572–578CrossRefPubMed

32.

Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, Mathisen O et al (2008) Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor. BMC Cancer 14(8):5CrossRef

33.

Jamieson NB, Foulis AK, Oien KA, Going JJ, Glen P, Dickson EJ et al (2010) Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma. Ann Surg 251(6):1003–1010CrossRefPubMed

34.

Pessaux P, Rosso E, Panaro F, Marzano E, Oussoultzoglou E, Bachellier P, Jaeck D (2009) Preliminary experience with the hanging maneuver for pancreaticoduodenectomy. Eur J Surg Oncol 35(9):1006–1010CrossRefPubMed

35.

Weitz J, Rahbari N, Koch M, Buchler MW (2010) The “artery first” approach for resection of pancreatic head cancer. J Am Coll Surg 210(2):e1–e4CrossRefPubMed

36.

Horiguchi A, Ishihara S, Ito M, Nagata H, Shimizu T, Furusawa K et al (2007) Pancreatoduodenectomy in which dissection of the efferent arteries of the head of the pancreas is performed first. J Hepatobiliary Pancreat Surg 14(6):575–578CrossRefPubMed

37.

Machado MC, Penteado S, Cunha JE, Jukemura J, Herman P, Bacchella T et al (2001) Pancreatic head tumors with portal vein involvement: an alternative surgical approach. Hepatogastroenterology 48(41):1486–1487PubMed

38.

Kawabata Y, Tanaka T, Nishi T, Monma H, Yano S, Tajima Y (2012) Appraisal of a total mesopancreatoduodenum excision with pancreaticoduodenectomy for pancreatic head carcinoma. Eur J Surg Oncol 38(7):574–579CrossRefPubMed

39.

Adham M, Singhirunnusorn J (2012) Surgical technique and results of total mesopancreas excision (TMpE) in pancreatic tumors. Eur J Surg Oncol 38(4):340–345. doi:10.1016/j.ejso.2011.12.015 CrossRefPubMed

40.

Varty PP, Yamamoto H, Farges O, Belghiti J, Sauvanet A (2005) Early retropancreatic dissection during pancreaticoduodenectomy. Am J Surg 189(4):488–491CrossRefPubMed

41.

Gaedcke J, Gunawan B, Grade M, Szoke R, Liersch T, Becker H et al (2010) The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials. Langenbecks Arch Surg 395(4):451–458CrossRefPubMedCentralPubMed

42.

Dumitrascu T, David L, Popescu I (2010) Posterior versus standard approach in pancreatoduodenectomy: a case-match study. Langenbecks Arch Surg 395(6):677–684CrossRefPubMedCentralPubMed

43.

Sanjay P, Takaori K, Govil S, Shrikhande SV, Windsor JA (2012) ‘Artery-first’ approaches to pancreatoduodenectomy. Br J Surg 99(8):1027–1035CrossRefPubMed

Title: Mesopancreas in Pancreatic Cancer: Where do We Stand – Review of Literature
Authors: Ramachandra Chowdappa
Vasu Reddy Challa
Publication date: 01-03-2015
Publisher: Springer India
Published in: Indian Journal of Surgical Oncology / Issue 1/2015
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI: https://doi.org/10.1007/s13193-014-0294-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Mesopancreas in Pancreatic Cancer: Where do We Stand – Review of Literature

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2015

Resection After Neoadjuvant Chemotherapy in Advanced Carcinoma of the Gallbladder: a Retrospective Study

Pancreatic Cancer in Chronic Pancreatitis

Advances in Chemotherapy for Pancreatic Cancer

Incidental Detection of Carcinoma Gall Bladder in Laparoscopic Cholecystectomy Specimens: A Thirteen Year Study of 23 Cases and Literature Review

Borderline Resectable Pancreatic Cancer

Serous Microcystic Adenoma to Adenocarcinoma of Pancreas—A Case Report